About Conference

The 20th World Congress on Vascular Dementia and Neurodegenerative Diseases is scheduled for July 07-08, 2025, in Zurich, Switzerland — a hub of scientific innovation and excellence in healthcare. This premier global event will spotlight the increasing prevalence of mixed dementia, a complex condition that involves both vascular dysfunction and neurodegenerative pathology, bridging the gap between research, clinical practice, and policy development.

With the theme, “Mixed Dementia: Understanding the Overlap Between Vascular and Neurodegenerative Pathologies,” the congress aims to explore the convergence of cerebrovascular and neurodegenerative diseases, enhancing understanding of their shared risk factors, diagnostic challenges, and therapeutic complexities. The event will provide a unique platform for knowledge exchange, collaborative networking, and multi-disciplinary dialogue, attracting thought leaders, clinical researchers, and industry innovators from around the world.

Why to Attend?

• International Exposure: Join a global gathering of dementia experts, researchers, and practitioners in a high-impact setting.
• Academic Excellence: Attend cutting-edge sessions on mixed dementia, biomarkers, neuroinflammation, neuroimaging, cerebrovascular research, and more.
• Collaborative Networking: Engage with experts across multiple fields—neurology, geriatrics, psychiatry, neuroscience, and pharmacology.
• Research Innovation: Discover the latest in translational research, early diagnosis techniques, digital therapeutics, and AI applications in dementia care.
• Career Development: Present your work, gain peer feedback, and explore publishing opportunities in leading journals and conference proceedings.
• Experience Zurich: Explore a city known for its medical research institutions, advanced healthcare systems, and cultural richness.

Who Should Attend?

This congress welcomes professionals and students involved in dementia and neuroscience-related fields, including:

• Neurologists
• Geriatricians and Internal Medicine Specialists
• Neuroscientists and Neurobiologists
• Psychiatrists and Clinical Psychologists
• Cognitive Neuroscience Researchers
• Pharmaceutical and Biotech Industry Leaders
• Health Informatics and AI Specialists
• Medical Students, Postdoctoral Fellows, and Research Scholars
• Healthcare Administrators and Public Health Officials
• Policy Makers and Government Representatives

Scientific Sessions/ Tracks

• Neurovascular Dysfunction and Cognitive Decline
• Stroke and Post-Stroke Dementia: Prevention and Management
• Hypertension, Diabetes, and Vascular Dementia Risk
• Cerebral Hypoperfusion and White Matter Lesions
• Role of Inflammation and Oxidative Stress in Vascular Dementia
• Blood-Brain Barrier Dysfunction in Vascular Dementia
• Machine Learning and AI in Early Vascular Dementia Diagnosis
• Mixed Dementia: The Overlapping Pathologies of Vascular and Neurodegenerative Dementia
• Lifestyle Modifications for Vascular Brain Health
• Drug Development and Emerging Therapies for Vascular Dementia
• Biomarkers for Early Diagnosis of Alzheimer’s and Parkinson’s Disease
• Tauopathies and Synucleinopathies: Molecular Mechanisms of Neurodegeneration
• Mitochondrial Dysfunction and Neurodegeneration
• Neuroinflammation, the Gut-Brain Axis, and Neurodegeneration
• Gene Therapy and CRISPR in Neurodegenerative Diseases
• Protein Misfolding and Aggregation in Neurodegenerative Disorders
• Advances in Neuroimaging for Neurodegenerative Disease Diagnosis
• Targeting Neurovascular Dysfunction in Neurodegenerative Diseases
• Personalized Medicine and Biomarker-Driven Approaches in Neurodegenerative Diseases
• The Future of Neurodegenerative Disease Therapy: Stem Cells and Regenerative Medicine

Benefits of Participation

• Knowledge Enrichment: Access over 50+ scientific sessions, keynote talks, and workshops across two immersive days.
• Global Collaboration: Meet peers from over 30 countries, fostering international partnerships and research alliances.
• Poster and Oral Presentations: Showcase your research, receive expert insights, and boost your academic profile.
• Certificate of Participation: Earn a signed certificate for CME/CPD accreditation and professional development.
• Publication Opportunity: Selected abstracts will be published in associated scientific journals or proceedings.
• Startup & Sponsorship Prospects: Connect with innovators, explore funding avenues, and engage with exhibitors and sponsors.
• Cultural Exchange: Enjoy networking dinners, poster walks, and city tours while engaging with global minds in one of Europe’s most beautiful cities.

Market Analysis

The global burden of vascular dementia and neurodegenerative diseases is rising rapidly. According to WHO, over 55 million people live with dementia worldwide, with nearly 10 million new cases diagnosed each year. Of these, a significant proportion exhibit mixed pathology, combining Alzheimer’s-type changes with cerebrovascular lesions, making diagnosis and treatment more challenging and pressing.

Key Market Insights:

• Global dementia market was valued at approximately USD 15.5 billion in 2023 and is projected to grow to USD 25.8 billion by 2030, driven by an aging population and growing public awareness.
• Advancements in molecular imaging, AI diagnostics, gene therapy, and biomarker research are fueling this growth.
• Europe remains a major player in the field, with Switzerland at the forefront due to its investments in neuroscience research, biotechnology, and personalized medicine.
• Increased funding for dementia-related clinical trials and innovative drug development is creating new opportunities for collaboration and commercialization.

Hosting this congress in Zurich aligns perfectly with the region’s leadership in neuroscience, offering an ideal environment for strategic partnerships and impactful scientific dialogue.